Bremner, Peter R.
Birk, Ruby
Brealey, Noushin
Ismaila, Afisi S.
Zhu, Chang-Qing
Lipson, David A.
Funding for this research was provided by:
GSK
Article History
Received: 7 November 2017
Accepted: 16 January 2018
First Online: 25 January 2018
Ethics approval and consent to participate
: The protocol was approved by applicable institutional review boards/ethics committees at each participating site, and was conducted in accordance with applicable regulatory requirements, ICH Good Clinical Practice guidelines, and the guiding principles of the Declaration of Helsinki. All patients provided written, informed consent prior to enrollment.
: Not applicable.
: RB, NB, ASI, C-QZ, and DAL are employees of GSK and hold stocks/shares in the company. ASI is also an unpaid faculty member at McMaster University, Canada. PRB has no conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.